A Goal-setting With Mentoring Lifestyle Modification Intervention to

Status Completed

Clinical Trial Summary

This is a 5-year project. In the 1st year of this study, a pilot randomized controlled trial evaluating the feasibility and acceptability of a goal-setting behavior change intervention aim at reducing modifiable risk factors for preventing cognitive decline. The aim of 2nd to 5th year of this study to investigate whether this multidomain intervention to optimize self-management of cognitive decline risk factors in older individuals, delivered through a mentor- supported interactive internet platform, can reduce the risk of cognitive decline.

Clinical Trial Description

Lifestyle factors playing a role in the development of late-life cognitive decline may be modifiable. There is a need for robust evidence about the potential for prevention of cognitive decline through behavior change interventions.

This study involves the development, implementation and initial testing of a behavior change intervention. At the 1st year, a small-scale randomized controlled trial (RCT) will investigate the implementation of a goal-setting intervention aim at promoting behavior change of personal modifiable risks for cognitive decline in the community for >55 years with at least one of the 7 modifiable risk factors for dementia. These older participants in the community (n = 100) will be randomized to either control (had a discussion regarding health and daily activity) or goal-setting with mentoring (the goal-setting interview involving identification of up to five personal goals of personal modifiable risks). All participants will be reassessed after 12 months. The 2nd to the 5th year, is a multisite, prospective, RCT with 36 months intervention. Recruitment of 300 older people (≥55 years) with at least one of the 7 modifiable risk factors for dementia will take place in Northern Taiwan. Participants randomised to the intervention condition will have access to an interactive internet platform, stimulating self-management of dementia risk factors, with remote mentoring by a mentor. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03900156
Study type	Interventional
Source	Chang Gung Memorial Hospital
Contact
Status	Completed
Phase	N/A
Start date	April 14, 2019
Completion date	June 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02007681` - What is in Fact the Contribution of Reducing Time Spent in Sedentary Behaviors on Daily Energy Expenditure? A Doubly Labeled Water Study	N/A
Completed	`NCT01395095` - OPTImal CArdiac REhabilitation (OPTICARE) Following Acute Coronary Syndromes	N/A
Active, not recruiting	`NCT00443586` - Follow-up Evaluation of Home Nurse Visitation Program for Socially Disadvantaged Women and Their Children	N/A
Completed	`NCT00438165` - Age 12 Follow-up of Early Preventive Intervention (Memphis)	N/A
Completed	`NCT04164277` - FirstStep2Health Intervention	N/A
Completed	`NCT04526873` - Encouraging Annual Wellness Visits Among ACO Beneficiaries	N/A
Completed	`NCT03196024` - Corazon de la Familia (Heart of the Family)	N/A
Completed	`NCT03287622` - Evaluation of an Interactive Opioid Risk Education Program (STOMP) for Parents	N/A
Not yet recruiting	`NCT01461798` - Assessment of the Efficacy of Plant Stanol Esters in Reducing Cholesterol, Medellin 2011	N/A
Withdrawn	`NCT01169922` - HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response	N/A
Completed	`NCT04853394` - Tajik Migrant Health Education Study	N/A
Completed	`NCT01291589` - HIV Prevention in Very High Risk Men Who Have Sex With Men	Phase 1
Completed	`NCT02311400` - Self-Affirmation, Emotion, and Alcohol Consumption
Completed	`NCT03863353` - Scenario Tailored Opioid Messaging Program (STOMP) to Improve Risk Understanding in Young Adults	N/A
Not yet recruiting	`NCT05732714` - Long Term Cardiovascular Disease Event Risk for Patients Undergoing Major Non-Cardiac Surgery
Not yet recruiting	`NCT02648555` - A Lifestyle Intervention to Improve in Vitro Fertilization Results	N/A
Completed	`NCT00443638` - Longitudinal Follow Up of Subjects Enrolled in Randomized Trial of Prenatal and Infancy Home Visitation	N/A
Completed	`NCT00906321` - Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer Risk	N/A
Active, not recruiting	`NCT04230928` - Giving a Low Carbohydrate Diet to Overcome Hypertension	N/A
Recruiting	`NCT05286879` - Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Goal-setting With Mentoring Lifestyle Modification Intervention to Reduce Risk of Dementia in Later Life

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms